JDD Special Focus

Acne Case Reports

Stay up-to-date on new clinical findings on Acne. View the latest articles, case reports, editorial features, supplements, Podcast episodes and more!

 

Case Reports

Microneedling for Treatment of Acne Scars: Considerations on the Successful Management of This Aesthetic Procedure

Microneedling is a minimally invasive procedure for treating acne scars which has already been well-established, but it has been reborn in recent years because of innovative findings. It presents many advantages in comparison with other techniques more frequently used such as laser resurfacing and deep chemical peelings; in particular, it consents to achieve good or excellent results with a minimal time (2-3 days) of recovery and rare complications, even in dark phototypes.1,2 

Read Now

Sponsored

Featured Unlocked Article

Integrating Dermocosmetic Therapy for Acne: Addressing Severity Levels in Real-Life Experiences

Treating acne is not just about prescriptions—it is about pairing the right skincare routine with medical therapy. This JDD article highlights how combining pharmacological treatments with a personalized dermocosmetic regimen can improve results and keep patients on track.

Read Now

Derm Atlas

One of the key characteristics of acne is post-inflammatory hyperpigmentation and is most noticeable in darker skin tones. It is also important to point out that keloidal or hypertrophic scarring may result and should be considered when treating patients.

Here we can appreciate the erythema of inflammatory papules in lighter skin tones and the brown coloration of inflammatory papules mimicking post-inflammatory hyperpigmentation in darker skin tones.

Read Now

Podcast Episodes

State of Acne Management: Stud or Dud?

Do not pop, rather pick a therapeutic strategy from the wide array of new….oh wait, nevermind.  The world of acne treatment R&D is unfortunately shrinking as payors pick away at the medical necessity of managing the most common inflammatory skin disease. Like Marty McFly fading in that famous family photo, the spotlight on acne is shifting, enough to make Dr. Pimple Punisher Dr. Hilary Baldwin pick up a bottle of Prozac. But all hope is not lost.

Join JDD Podcast host Dr. Adam Friedman as he and Dr. Baldwin scour the therapeutic landscape and take a sharp left into the over the counter space to review accessible options to manage both the today and tomorrow of Acne Vulgaris, the symbiosis between RX and OTC to address barrier dysfunction, scarring and hyperpigmentation.

Listen Now

Sponsored

Dermatology News

Journal of Drugs in Dermatology JDD Article About Ruxolitinib Cream Versus Triamcinolone Cream in Adults With Mild to Moderate Atopic DermatitisAtopic DermatitisFeatured ArticlesLatest NewsThe Latest
October 10, 2025

Ruxolitinib Cream Versus Triamcinolone Cream in Adults With Mild to Moderate Atopic Dermatitis

Fast itch relief and comparable skin clearance at week 4 - a nonsteroidal option to note for mild-moderate AD In a phase 2, dose‑ranging trial, twice‑daily 1.5% ruxolitinib cream matched…
Journal of Drugs in Dermatology JDD Article About 1% Colloidal Oatmeal Cream/Baby Wash Regimen Improved Atopic Dermatitis in Pediatric Patients From First UseAtopic DermatitisFeatured ArticlesLatest NewsPediatricsThe Latest
October 9, 2025

1% Colloidal Oatmeal Cream/Baby Wash Regimen Improved Atopic Dermatitis in Pediatric Patients From First Use

A simple 1% colloidal oatmeal regimen cut itch and improved eczema scores within days in toddlers A small open‑label study in children aged 3-72 months tested a twice‑daily 1% colloidal…
Journal of Drugs in Dermatology JDD Article About Examining an Antioxidant Biostimulating Treatment for Dark, Postinflammatory Hyperpigmentation-Prone Skin. Concentrates on skin of colorDyspigmentationFeatured ArticlesLatest NewsSkin of ColorThe Latest
October 8, 2025

Examining an Antioxidant Biostimulating Treatment for Dark, Postinflammatory Hyperpigmentation-Prone Skin

A multi-acid, antioxidant delivery approach that promises boost in radiance and texture without PIH.  Worth a look for patients with FST V–VI Facial rejuvenation that's both effective and safe in…
Journal of Drugs in Dermatology JDD Article About Refractory Pruritus Secondary to Linear IgA Bullous Dermatosis Treated Successfully With Nemolizumab: A Case ReportCase ReportsFeatured ArticlesLatest NewsMedical DermThe Latest
October 7, 2025

In Memoriam: Ronald Moy MD (1957-2025)

Honoring The Life of a Giant in Dermatologic Surgery We are all mourning the untimely passing of our esteemed colleague and friend, Dr Ron Moy, in July 2025. Dr Moy…